These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16464479)

  • 1. Phenacetin acts as a weak genotoxic compound preferentially in the kidney of DNA repair deficient Xpa mice.
    Luijten M; Speksnijder EN; van Alphen N; Westerman A; Heisterkamp SH; van Benthem J; van Kreijl CF; Beems RB; van Steeg H
    Mutat Res; 2006 Apr; 596(1-2):143-50. PubMed ID: 16464479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
    van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
    Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
    Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
    Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models.
    Jonker MJ; Bruning O; van Iterson M; Schaap MM; van der Hoeven TV; Vrieling H; Beems RB; de Vries A; van Steeg H; Breit TM; Luijten M
    Carcinogenesis; 2009 Oct; 30(10):1805-12. PubMed ID: 19696161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
    Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
    Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation spectrum in UVB-exposed skin epidermis of Xpa-knockout mice: frequent recovery of triplet mutations.
    Ikehata H; Yanase F; Mori T; Nikaido O; Tanaka K; Ono T
    Environ Mol Mutagen; 2007 Jan; 48(1):1-13. PubMed ID: 17163503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
    van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
    Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
    Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated accumulation of somatic mutations in mice deficient in the nucleotide excision repair gene XPA.
    Giese H; Dollé ME; Hezel A; van Steeg H; Vijg J
    Oncogene; 1999 Feb; 18(5):1257-60. PubMed ID: 10022133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
    Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
    Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H
    Cancer Res; 2000 Oct; 60(20):5681-7. PubMed ID: 11059760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice.
    Bol SA; van Steeg H; Jansen JG; Van Oostrom C; de Vries A; de Groot AJ; Tates AD; Vrieling H; van Zeeland AA; Mullenders LH
    Cancer Res; 1998 Jul; 58(13):2850-6. PubMed ID: 9661901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
    de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
    DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
    van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
    Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between UV-induced mutant p53 patches and skin tumours, analysed by mutation spectra and by induction kinetics in various DNA-repair-deficient mice.
    Rebel H; Kram N; Westerman A; Banus S; van Kranen HJ; de Gruijl FR
    Carcinogenesis; 2005 Dec; 26(12):2123-30. PubMed ID: 16051635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors.
    Ide F; Iida N; Nakatsuru Y; Oda H; Tanaka K; Ishikawa T
    Carcinogenesis; 2000 Jun; 21(6):1263-5. PubMed ID: 10837020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?
    van Kesteren PC; Beems RB; Luijten M; Robinson J; de Vries A; van Steeg H
    Carcinogenesis; 2009 Mar; 30(3):538-43. PubMed ID: 19136475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.
    de Vries A; van Oostrom CT; Dortant PM; Beems RB; van Kreijl CF; Capel PJ; van Steeg H
    Mol Carcinog; 1997 May; 19(1):46-53. PubMed ID: 9180928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
    de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
    Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.